Posters Clinical Microbiology and Infection

Slides:

Advertisements

Similar presentations

Is Anti-Hepatitis C Virus Antibody Level an Appropriate Marker to Preclude the Need for Supplemental Testing? Intervirology 2015;58: DOI: /

Advertisements

Cryptococcosis—the impact of delay to diagnosis

Thirty-day mortality of nosocomial systemic bacterial infections according to antibiotic susceptibility in an 800-bed teaching hospital in France D.

L. Boyanova Clinical Microbiology and Infection

The Panton–Valentine leukocidin vaccine protects mice against lung and skin infections caused by Staphylococcus aureus USA300 E.L. Brown, O. Dumitrescu,

C. Steininger, M. Redlberger, W. Graninger, M. Kundi, T. Popow-Kraupp

Evaluation of a commercial IgE ELISA in comparison with IgA and IgM ELISAs, IgG avidity assay and complement fixation for the diagnosis of acute toxoplasmosis

Detection of fungal DNA in lysis–centrifugation blood culture for the diagnosis of invasive candidiasis in neonatal patients L. Trovato, P. Betta, M.G.

A. Pierro, S. Ficarelli, N. Ayhan, S. Morini, L. Raumer, M

Approach to diagnosis of infective endocarditis

C-reactive protein as a marker of infection in critically ill patients

Clinical Microbiology and Infection

P. Clarke, S. Murchan, E.G. Smyth, H. Humphreys

Serological testing for Bartonella henselae infections in The Netherlands: clinical evaluation of immunofluorescence assay and ELISA M.J. Vermeulen,

Cross-reaction between Yersinia outer membrane proteins and anti-Borreli antibodies in sera of patients with Lyme disease E. Golkocheva-Markova, I. Christova,

Oral presentations Clinical Microbiology and Infection

Increased levels of immunological markers in the respiratory tract but not in serum correlate with active pulmonary mycobacterial infection in mice J.

The microarray technology: facts and controversies

G. Zhao, H. Zhai, Q. Yuan, S. Sun, T. Liu, L. Xie

Gentamicin susceptibility in Escherichia coli related to the genetic background: problems with breakpoints L. Jakobsen, D. Sandvang, V.F. Jensen, A.M.

A. Pierro, S. Ficarelli, N. Ayhan, S. Morini, L. Raumer, M

Current patterns and evolution of antibiotic resistance among bacterial pathogens involved in acute otitis media Fernando Baquero, Rafael Cantón, Fernando.

Clinical Microbiology and Infection

Link between intracellular pathogens and cardiovascular diseases

How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development R. Bax Clinical Microbiology.

Non-antibiotic strategies for sepsis

Impact of changes in CLSI and EUCAST breakpoints for susceptibility in bloodstream infections due to extended-spectrum β-lactamase-producing Escherichia.

W. Witte, B. Pasemann, C. Cuny Clinical Microbiology and Infection

Oral presentations Clinical Microbiology and Infection

Clinical Microbiology and Infection

M. Nørgaard, H. Larsson, G. Pedersen, H.C. Schønheyder, H.T. Sørensen

P. Moreillon, J.M. Entenza Clinical Microbiology and Infection

Prevalence of Yersinia plasmid-encoded outer protein (Yop) class-specific antibodies in patients with Hashimoto's thyroiditis S. Chatzipanagiotou, J.N.

Correlation of quinolone resistance levels and differences in basal and quinolone- induced expression from three qnrA-containing plasmids J.M. Rodríguez-Martínez,

Late Breaking News Clinical Microbiology and Infection

Covering the Cover Gastroenterology

Aspergillus PCR in serum for the diagnosis, follow-up and prognosis of invasive aspergillosis in neutropenic and nonneutropenic patients S. Imbert, L.

Sofie Arens, Jan Verhaegen, Ludo Verbist

G. Höffken Clinical Microbiology and Infection

Retrospective study of CMV retinitis in patients with AIDS

Epidemiology of opportunistic infections in AIDS patients

Comparative in vitro activity of ertapenem against bacterial pathogens isolated from patients with lower respiratory tract infections P.S. Hicks, B.

Clinical Microbiology and Infection Volume 9, Pages (January 2003)

M.N. Al-Hasan, B.D. Lahr, J.E. Eckel-Passow, L.M. Baddour

Levofloxacin in the treatment of ventilator-associated pneumonia

Baseline C-reactive protein level as a predictor of mortality in bacteraemia patients: a population-based cohort study K.O. Gradel, R.W. Thomsen, S.

S8 – S47 and O50 – O440 Clinical Microbiology and Infection

Symposia and Oral Presentations

Harmonised monitoring of antimicrobial resistance in Salmonella and Campylobacter isolates from food animals in the European Union S. Bronzwaer Clinical.

Diagnostic value of an ELISA using a recombinant 54-kDa species-specific protein from Chlamydia pneumoniae J-M. Sueur, K. Beaumont, T. Cabioch, J. Orfila,

Community-acquired pneumonia: epidemiologic and clinical consideration

Abstracts cont. Clinical Microbiology and Infection

Evaluation of eight commercial tests for Mycoplasma pneumoniae antibodies in the absence of acute infection R. Nir-Paz, A. Michael-Gayego, M. Ron, C.

C. Oprica, C.E. Nord Clinical Microbiology and Infection

Correlation between clinical data and antibiotic resistance in coagulase-negative Staphylococcus species isolated from 68 patients with acute post-cataract.

Definition of the Clinical Antibacterial Spectrum of Activity

M.B. Kerrn, N. Frimodt-Møller, F. Espersen

Evaluation of the CLSI cefoxitin 30-µg disk-diffusion method for detecting methicillin resistance in staphylococci L.-X. Zhu, Z.-W. Zhang, C. Wang, H.-W.

Lymphocyte subset numbers depend on the bacterial origin of sepsis

Evaluation of diagnostic tests

Serum antibodies against Panton–Valentine leukocidin in a normal population and during Staphylococcus aureus infection M. Croze, O. Dauwalder, O. Dumitrescu,

Terminology relating to methods for the determination of susceptibility of bacteria to antimicrobial agents Clinical Microbiology and Infection Volume.

Abstracts accepted for publication only

Modification of prescribers’ behavior: the Icelandic approach

G. Kahlmeter Clinical Microbiology and Infection

Decision-making in otitis media in children, Part I: epidemiologic data and definitions for a reliable cost-effectiveness analysis Bernard Grenier Clinical.

Abstracts Clinical Microbiology and Infection

Clinical Microbiology and Infection

Therapeutic hFIX Activity Achieved after Single AAV5-hFIX Treatment in Hemophilia B Patients and NHPs with Pre-existing Anti-AAV5 NABs Anna Majowicz,

23. Clinical laboratory assessment of IgE-dependent hypersensitivity

Presentation transcript:

Posters Clinical Microbiology and Infection Clinical Microbiology and Infection Volume 13, Pages S109-S608 (January 2007) DOI: 10.1111/j.1469-0691.2007.01733.x Copyright © 2007 Terms and Conditions

Figure 1 D-HPLC profiles of 16S products from chicken faeces. Clinical Microbiology and Infection 2007 13, S109-S608DOI: (10.1111/j.1469-0691.2007.01733.x) Copyright © 2007 Terms and Conditions

Mean microbiocidal effect of CHX on bacterial residues. Clinical Microbiology and Infection 2007 13, S109-S608DOI: (10.1111/j.1469-0691.2007.01733.x) Copyright © 2007 Terms and Conditions

Figure 1 Effect of anti-C1q on haemolysis in the haemolytic MBL assay in (a) three selected ASCA-positive sera and (b) 35 sera of known genotypes. Clinical Microbiology and Infection 2007 13, S109-S608DOI: (10.1111/j.1469-0691.2007.01733.x) Copyright © 2007 Terms and Conditions

% of qnr in ECL Clinical Microbiology and Infection 2007 13, S109-S608DOI: (10.1111/j.1469-0691.2007.01733.x) Copyright © 2007 Terms and Conditions

Clinical Microbiology and Infection 2007 13, S109-S608DOI: (10. 1111/j Clinical Microbiology and Infection 2007 13, S109-S608DOI: (10.1111/j.1469-0691.2007.01733.x) Copyright © 2007 Terms and Conditions

Clinical Microbiology and Infection 2007 13, S109-S608DOI: (10. 1111/j Clinical Microbiology and Infection 2007 13, S109-S608DOI: (10.1111/j.1469-0691.2007.01733.x) Copyright © 2007 Terms and Conditions

Clinical Microbiology and Infection 2007 13, S109-S608DOI: (10. 1111/j Clinical Microbiology and Infection 2007 13, S109-S608DOI: (10.1111/j.1469-0691.2007.01733.x) Copyright © 2007 Terms and Conditions

Clinical Microbiology and Infection 2007 13, S109-S608DOI: (10. 1111/j Clinical Microbiology and Infection 2007 13, S109-S608DOI: (10.1111/j.1469-0691.2007.01733.x) Copyright © 2007 Terms and Conditions

Clinical Microbiology and Infection 2007 13, S109-S608DOI: (10. 1111/j Clinical Microbiology and Infection 2007 13, S109-S608DOI: (10.1111/j.1469-0691.2007.01733.x) Copyright © 2007 Terms and Conditions

Clinical Microbiology and Infection 2007 13, S109-S608DOI: (10. 1111/j Clinical Microbiology and Infection 2007 13, S109-S608DOI: (10.1111/j.1469-0691.2007.01733.x) Copyright © 2007 Terms and Conditions

Clinical Microbiology and Infection 2007 13, S109-S608DOI: (10. 1111/j Clinical Microbiology and Infection 2007 13, S109-S608DOI: (10.1111/j.1469-0691.2007.01733.x) Copyright © 2007 Terms and Conditions

Clinical Microbiology and Infection 2007 13, S109-S608DOI: (10. 1111/j Clinical Microbiology and Infection 2007 13, S109-S608DOI: (10.1111/j.1469-0691.2007.01733.x) Copyright © 2007 Terms and Conditions

Fig. 1 Clinical Microbiology and Infection 2007 13, S109-S608DOI: (10.1111/j.1469-0691.2007.01733.x) Copyright © 2007 Terms and Conditions

Clinical Microbiology and Infection 2007 13, S109-S608DOI: (10. 1111/j Clinical Microbiology and Infection 2007 13, S109-S608DOI: (10.1111/j.1469-0691.2007.01733.x) Copyright © 2007 Terms and Conditions

Clinical Microbiology and Infection 2007 13, S109-S608DOI: (10. 1111/j Clinical Microbiology and Infection 2007 13, S109-S608DOI: (10.1111/j.1469-0691.2007.01733.x) Copyright © 2007 Terms and Conditions

Fig. 1 Correlation between bacterial DNA load and C-reactive protein. Clinical Microbiology and Infection 2007 13, S109-S608DOI: (10.1111/j.1469-0691.2007.01733.x) Copyright © 2007 Terms and Conditions

Clinical Microbiology and Infection 2007 13, S109-S608DOI: (10. 1111/j Clinical Microbiology and Infection 2007 13, S109-S608DOI: (10.1111/j.1469-0691.2007.01733.x) Copyright © 2007 Terms and Conditions

MRSA isolates from the Netherlands, 2003–2006. Clinical Microbiology and Infection 2007 13, S109-S608DOI: (10.1111/j.1469-0691.2007.01733.x) Copyright © 2007 Terms and Conditions

Age distribution of 122 ciprofloxacin-susceptible MRSA isolates from 2000–2005 compared with all 27,422 MRSA isolates at Guy's and St. Thomas' NHS Foundation Trust from 2001–2004. Clinical Microbiology and Infection 2007 13, S109-S608DOI: (10.1111/j.1469-0691.2007.01733.x) Copyright © 2007 Terms and Conditions

Scattergram showing correlation between levofloxacin and moxifloxacin MIC results for S. maltophilia. Solid lines indicate CLSI breakpoints, dashed lines indicates EUCAST breakpoints. Clinical Microbiology and Infection 2007 13, S109-S608DOI: (10.1111/j.1469-0691.2007.01733.x) Copyright © 2007 Terms and Conditions

MIC of mecillinam +/− clavulanate for ESBL-producing E. coli. Clinical Microbiology and Infection 2007 13, S109-S608DOI: (10.1111/j.1469-0691.2007.01733.x) Copyright © 2007 Terms and Conditions

Fig. 1 Clinical Microbiology and Infection 2007 13, S109-S608DOI: (10.1111/j.1469-0691.2007.01733.x) Copyright © 2007 Terms and Conditions

Fig. 1 Clinical Microbiology and Infection 2007 13, S109-S608DOI: (10.1111/j.1469-0691.2007.01733.x) Copyright © 2007 Terms and Conditions

Figure 1 HCV genotyping: agreement between results of LiPA and real-time PCR assays. Clinical Microbiology and Infection 2007 13, S109-S608DOI: (10.1111/j.1469-0691.2007.01733.x) Copyright © 2007 Terms and Conditions

Clinical Microbiology and Infection 2007 13, S109-S608DOI: (10. 1111/j Clinical Microbiology and Infection 2007 13, S109-S608DOI: (10.1111/j.1469-0691.2007.01733.x) Copyright © 2007 Terms and Conditions

Fig. 1 Incidence density of surgical site infections/1000 post-op inpatient days in HPRO (+95% CI) by country, HELICS-SSI, cumulative data for 2004–2005. Clinical Microbiology and Infection 2007 13, S109-S608DOI: (10.1111/j.1469-0691.2007.01733.x) Copyright © 2007 Terms and Conditions

Clinical Microbiology and Infection 2007 13, S109-S608DOI: (10. 1111/j Clinical Microbiology and Infection 2007 13, S109-S608DOI: (10.1111/j.1469-0691.2007.01733.x) Copyright © 2007 Terms and Conditions

Effect of Amphotericin B on the survival index of four L Effect of Amphotericin B on the survival index of four L. donovani amastigotes infecting a J774-cell line. Clinical Microbiology and Infection 2007 13, S109-S608DOI: (10.1111/j.1469-0691.2007.01733.x) Copyright © 2007 Terms and Conditions

Clinical Microbiology and Infection 2007 13, S109-S608DOI: (10. 1111/j Clinical Microbiology and Infection 2007 13, S109-S608DOI: (10.1111/j.1469-0691.2007.01733.x) Copyright © 2007 Terms and Conditions

Clinical Microbiology and Infection 2007 13, S109-S608DOI: (10. 1111/j Clinical Microbiology and Infection 2007 13, S109-S608DOI: (10.1111/j.1469-0691.2007.01733.x) Copyright © 2007 Terms and Conditions

Clinical Microbiology and Infection 2007 13, S109-S608DOI: (10. 1111/j Clinical Microbiology and Infection 2007 13, S109-S608DOI: (10.1111/j.1469-0691.2007.01733.x) Copyright © 2007 Terms and Conditions

Fig. 1 Probable transmission of P. jirovecii infection from grandparents to infant. Clinical Microbiology and Infection 2007 13, S109-S608DOI: (10.1111/j.1469-0691.2007.01733.x) Copyright © 2007 Terms and Conditions

Clinical Microbiology and Infection 2007 13, S109-S608DOI: (10. 1111/j Clinical Microbiology and Infection 2007 13, S109-S608DOI: (10.1111/j.1469-0691.2007.01733.x) Copyright © 2007 Terms and Conditions

Antibiotic cost in USD per patient day in Cardiothoracic ICU. Clinical Microbiology and Infection 2007 13, S109-S608DOI: (10.1111/j.1469-0691.2007.01733.x) Copyright © 2007 Terms and Conditions

Clinical Microbiology and Infection 2007 13, S109-S608DOI: (10. 1111/j Clinical Microbiology and Infection 2007 13, S109-S608DOI: (10.1111/j.1469-0691.2007.01733.x) Copyright © 2007 Terms and Conditions

Left: CIA strip for detecting anti-O Left: CIA strip for detecting anti-O. tsutsugamushi total antibodies in serum: (a) positive and (b) negative result. Right: CIA strip for diagnosis of anti-O. tsutsugamushi IgG and IgM in serum: (a) IgG+/IgM+, (b) IgG+/IgM–, (c) IgG–/IgM+, (d) IgG–/IgM–. Clinical Microbiology and Infection 2007 13, S109-S608DOI: (10.1111/j.1469-0691.2007.01733.x) Copyright © 2007 Terms and Conditions

Clinical Microbiology and Infection 2007 13, S109-S608DOI: (10. 1111/j Clinical Microbiology and Infection 2007 13, S109-S608DOI: (10.1111/j.1469-0691.2007.01733.x) Copyright © 2007 Terms and Conditions

Clinical Microbiology and Infection 2007 13, S109-S608DOI: (10. 1111/j Clinical Microbiology and Infection 2007 13, S109-S608DOI: (10.1111/j.1469-0691.2007.01733.x) Copyright © 2007 Terms and Conditions

ROC curves of three predictive markers for mortality in patients with sepsis. Clinical Microbiology and Infection 2007 13, S109-S608DOI: (10.1111/j.1469-0691.2007.01733.x) Copyright © 2007 Terms and Conditions

Clinical Microbiology and Infection 2007 13, S109-S608DOI: (10. 1111/j Clinical Microbiology and Infection 2007 13, S109-S608DOI: (10.1111/j.1469-0691.2007.01733.x) Copyright © 2007 Terms and Conditions

Figure 1 Infected mice. Infection of the group A (triangle) and the group B (quadrate) mice with pathogen S. enteritidis was detected by plate count of faeces, liver or spleen onto selective media XLD. Clinical Microbiology and Infection 2007 13, S109-S608DOI: (10.1111/j.1469-0691.2007.01733.x) Copyright © 2007 Terms and Conditions

OVA-specific IgE levels in study and control group. Clinical Microbiology and Infection 2007 13, S109-S608DOI: (10.1111/j.1469-0691.2007.01733.x) Copyright © 2007 Terms and Conditions

Clinical Microbiology and Infection 2007 13, S109-S608DOI: (10. 1111/j Clinical Microbiology and Infection 2007 13, S109-S608DOI: (10.1111/j.1469-0691.2007.01733.x) Copyright © 2007 Terms and Conditions

Clinical Microbiology and Infection 2007 13, S109-S608DOI: (10. 1111/j Clinical Microbiology and Infection 2007 13, S109-S608DOI: (10.1111/j.1469-0691.2007.01733.x) Copyright © 2007 Terms and Conditions

Clinical Microbiology and Infection 2007 13, S109-S608DOI: (10. 1111/j Clinical Microbiology and Infection 2007 13, S109-S608DOI: (10.1111/j.1469-0691.2007.01733.x) Copyright © 2007 Terms and Conditions

Clinical Microbiology and Infection 2007 13, S109-S608DOI: (10. 1111/j Clinical Microbiology and Infection 2007 13, S109-S608DOI: (10.1111/j.1469-0691.2007.01733.x) Copyright © 2007 Terms and Conditions

Clinical Microbiology and Infection 2007 13, S109-S608DOI: (10. 1111/j Clinical Microbiology and Infection 2007 13, S109-S608DOI: (10.1111/j.1469-0691.2007.01733.x) Copyright © 2007 Terms and Conditions

Clinical Microbiology and Infection 2007 13, S109-S608DOI: (10. 1111/j Clinical Microbiology and Infection 2007 13, S109-S608DOI: (10.1111/j.1469-0691.2007.01733.x) Copyright © 2007 Terms and Conditions

Clinical Microbiology and Infection 2007 13, S109-S608DOI: (10. 1111/j Clinical Microbiology and Infection 2007 13, S109-S608DOI: (10.1111/j.1469-0691.2007.01733.x) Copyright © 2007 Terms and Conditions

Clinical Microbiology and Infection 2007 13, S109-S608DOI: (10. 1111/j Clinical Microbiology and Infection 2007 13, S109-S608DOI: (10.1111/j.1469-0691.2007.01733.x) Copyright © 2007 Terms and Conditions

Clinical Microbiology and Infection 2007 13, S109-S608DOI: (10. 1111/j Clinical Microbiology and Infection 2007 13, S109-S608DOI: (10.1111/j.1469-0691.2007.01733.x) Copyright © 2007 Terms and Conditions